
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
LI-cadherin CRISPR/Cas9 KO Plasmid (h) | sc-401229 | 20 µg | $397.00 |
CDH17 encodes LI-cadherin, a non-classical cadherin enriched in intestinal epithelium that mediates calcium-dependent cell–cell adhesion and contributes to epithelial polarity and barrier function. Unlike classical cadherins, LI-cadherin lacks the canonical catenin-binding domain, linking it to distinct mechanisms controlling junctional organization, tissue architecture, and cell sorting. Altered CDH17 expression and localization are frequently investigated in gastrointestinal epithelial remodeling and tumor-associated changes in adhesion, invasion, and differentiation programs. As a lineage-associated adhesion molecule, LI-cadherin is also used to study how membrane adhesion receptors interface with cytoskeletal regulation, contact inhibition, and microenvironmental cues.
LI-cadherin CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CDH17 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CDH17 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CDH17 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish LI-cadherin protein expression.
This CRISPR knockout system enables efficient generation of CDH17-deficient cell models for investigation of LI-cadherin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.